Select Page

Nevro recruits first patient in PDN Sensory Study

Multiple sites across the US will be used to enrol up to 236 patients in the study. Medical device company Nevro has recruited the first patient for the Painful Diabetic Neuropathy (PDN) Sensory Study. The objective of the randomised controlled trial is to assess the...